Skip to main content
Springer logoLink to Springer
. 2025 Apr 9;27(8):3558. doi: 10.1007/s12094-025-03912-2

Correction: Management and outcome of children with high‑risk neuroblastoma: insights from the Spanish Society of Pediatric Hematology and Oncology (SEHOP) neuroblastoma group on refractory and relapse/progressive disease

Blanca Martínez de las Heras 1,7,, Pedro M Rubio-Aparicio 2, Alba Rubio-San-Simón 3, Lucas Moreno 4, Paula Mazorra 4, Ricardo López Almaraz 5, Mercedes Llempén López 6, Julia Balaguer Guill 1,7, Vanessa Segura 7, Mar Bermúdez 8, Irene Jiménez 8, Désirée Ramal 7, Adela Cañete 1,7
PMCID: PMC12259784  PMID: 40202583

Correction: Clinical and Translational Oncology 10.1007/s12094-025-03853-w

In this article the statement in the Funding information section was incorrectly given as ‘Publication funded by the European Union-Next GenerationEU’ and should have read ‘This study has been co-funded by Instituto de Salud Carlos III (ISCIII) through the project “ICI21/00098” with funds from Plan de Recuperación, Transformación y Resiliencia and “Funded by the European Union – NextGenerationEU”’.

The original article has been corrected.

Footnotes

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.


Articles from Clinical & Translational Oncology are provided here courtesy of Springer

RESOURCES